Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$269.27+0.15 (+0.06%)
Delayed quote: Sep 9, 2026, 10:05 AM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 9, 2026, 10:05 AM EDT
The latest quarterly PP&E is $23.58 Billion with a quarter-over-quarter change of -56.88%. Property, Plant & Equipment (PP&E) represents the long-term tangible assets used in operations, including land, buildings, machinery, and equipment, shown net of accumulated depreciation.
Reported quarterly PP&E; no daily interpolation.
$23.58B
$23.58 Billion
-56.88%
vs. $54.70B prior quarter
96
Quarters of data available
| Period | PP&E | QoQ Change | % Change |
|---|---|---|---|
| Quarter ended Jun 2026 | $23.58B | −$31.11B | -56.88% |
| Quarter ended Mar 2026 | $54.70B | +$31.53B | +136.07% |
| Quarter ended Dec 2025 | $23.17B | −$30.21B | -56.59% |
| Quarter ended Sep 2025 | $53.38B | +$31.43B | +143.18% |
| Quarter ended Jun 2025 | $21.95B | +$1.08B | +5.17% |
| Quarter ended Mar 2025 | $20.87B | +$353.00M | +1.72% |
| Quarter ended Dec 2024 | $20.52B | +$39.00M | +0.19% |
| Quarter ended Sep 2024 | $20.48B | +$731.00M | +3.70% |
| Quarter ended Jun 2024 | $19.75B | +$116.00M | +0.59% |
| Quarter ended Mar 2024 | $19.63B | −$266.00M | -1.34% |
| Quarter ended Dec 2023 | $19.90B | +$1.08B | +5.72% |
| Quarter ended Oct 2023 | $18.82B | −$1.75B | -8.53% |
| Quarter ended Jul 2023 | $20.58B | +$402.00M | +1.99% |
| Quarter ended Apr 2023 | $20.17B | +$2.19B | +12.19% |
| Quarter ended Dec 2022 | $17.98B | −$170.00M | -0.94% |
| Quarter ended Oct 2022 | $18.15B | −$202.00M | -1.10% |
| Quarter ended Jul 2022 | $18.35B | −$347.00M | -1.86% |
| Quarter ended Apr 2022 | $18.70B | −$261.00M | -1.38% |
| Quarter ended Dec 2021 | $18.96B | +$484.00M | +2.62% |
| Quarter ended Oct 2021 | $18.48B | −$154.00M | -0.83% |
| Quarter ended Jul 2021 | $18.63B | +$265.00M | +1.44% |
| Quarter ended Apr 2021 | $18.37B | −$399.00M | -2.13% |
| Quarter ended Dec 2020 | $18.77B | +$911.00M | +5.10% |
| Quarter ended Sep 2020 | $17.86B | +$257.00M | +1.46% |
| Quarter ended Jun 2020 | $17.60B | +$197.00M | +1.13% |
| Quarter ended Mar 2020 | $17.40B | −$257.00M | -1.46% |
| Quarter ended Dec 2019 | $17.66B | +$610.00M | +3.58% |
| Quarter ended Sep 2019 | $17.05B | −$200.00M | -1.16% |
| Quarter ended Jun 2019 | $17.25B | +$248.00M | +1.46% |
| Quarter ended Mar 2019 | $17.00B | −$35.00M | -0.21% |
| Quarter ended Dec 2018 | $17.04B | +$406.00M | +2.44% |
| Quarter ended Sep 2018 | $16.63B | −$3.00M | -0.02% |
| Quarter ended Jul 2018 | $16.63B | −$408.00M | -2.39% |
| Quarter ended Apr 2018 | $17.04B | +$35.00M | +0.21% |
| Quarter ended Dec 2017 | $17.00B | +$377.00M | +2.27% |
| Quarter ended Oct 2017 | $16.63B | +$170.00M | +1.03% |
| Quarter ended Jul 2017 | $16.46B | +$267.00M | +1.65% |
| Quarter ended Apr 2017 | $16.19B | +$279.00M | +1.75% |
| Quarter ended Dec 2016 | $15.91B | −$183.00M | -1.14% |
| Quarter ended Oct 2016 | $16.09B | +$123.00M | +0.77% |
| Quarter ended Jul 2016 | $15.97B | +$8.00M | +0.05% |
| Quarter ended Apr 2016 | $15.96B | +$59.00M | +0.37% |
| Quarter ended Dec 2015 | $15.90B | +$354.00M | +2.28% |
| Quarter ended Sep 2015 | $15.55B | −$32.00M | -0.21% |
| Quarter ended Jun 2015 | $15.58B | +$219.00M | +1.43% |
| Quarter ended Mar 2015 | $15.36B | −$762.00M | -4.73% |
| Quarter ended Dec 2014 | $16.13B | +$322.00M | +2.04% |
| Quarter ended Sep 2014 | $15.80B | −$351.00M | -2.17% |
| Quarter ended Jun 2014 | $16.16B | +$159.00M | +0.99% |
| Quarter ended Mar 2014 | $16.00B | −$714.00M | -4.27% |
| Quarter ended Dec 2013 | $16.71B | +$583.00M | +3.62% |
| Quarter ended Sep 2013 | $16.13B | +$333.00M | +2.11% |
| Quarter ended Jun 2013 | $15.79B | +$73.00M | +0.46% |
| Quarter ended Mar 2013 | $15.72B | −$376.00M | -2.34% |
| Quarter ended Dec 2012 | $16.10B | +$252.00M | +1.59% |
| Quarter ended Sep 2012 | $15.85B | +$223.00M | +1.43% |
| Quarter ended Jul 2012 | $15.62B | +$798.00M | +5.38% |
| Quarter ended Apr 2012 | $14.82B | +$85.00M | +0.58% |
| Quarter ended Dec 2011 | $14.74B | +$104.00M | +0.71% |
| Quarter ended Oct 2011 | $14.63B | −$339.00M | -2.26% |
| Quarter ended Jul 2011 | $14.97B | −$110.00M | -0.73% |
| Quarter ended Apr 2011 | $15.08B | +$531.00M | +3.65% |
| Quarter ended Dec 2010 | $14.55B | +$193.00M | +1.34% |
| Quarter ended Oct 2010 | $14.36B | +$479.00M | +3.45% |
| Quarter ended Jul 2010 | $13.88B | −$396.00M | -2.77% |
| Quarter ended Apr 2010 | $14.28B | −$482.00M | -3.27% |
| Quarter ended Dec 2009 | $14.76B | −$56.00M | -0.38% |
| Quarter ended Sep 2009 | $14.81B | +$313.00M | +2.16% |
| Quarter ended Jun 2009 | $14.50B | +$249.00M | +1.75% |
| Quarter ended Mar 2009 | $14.25B | −$112.00M | -0.78% |
| Quarter ended Dec 2008 | $14.37B | +$10.00M | +0.07% |
| Quarter ended Sep 2008 | $14.36B | −$272.00M | -1.86% |
| Quarter ended Jun 2008 | $14.63B | +$141.00M | +0.97% |
| Quarter ended Mar 2008 | $14.49B | +$301.00M | +2.12% |
| Quarter ended Dec 2007 | $14.19B | +$572.00M | +4.20% |
| Quarter ended Sep 2007 | $13.61B | +$228.00M | +1.70% |
| Quarter ended Jul 2007 | $13.38B | +$205.00M | +1.56% |
| Quarter ended Apr 2007 | $13.18B | +$136.00M | +1.04% |
| Quarter ended Dec 2006 | $13.04B | +$1.58B | +13.80% |
| Quarter ended Oct 2006 | $11.46B | +$175.00M | +1.55% |
| Quarter ended Jul 2006 | $11.29B | +$336.00M | +3.07% |
| Quarter ended Apr 2006 | $10.95B | +$121.00M | +1.12% |
| Quarter ended Dec 2005 | $10.83B | +$603.00M | +5.90% |
| Quarter ended Oct 2005 | $10.23B | +$136.00M | +1.35% |
| Quarter ended Jul 2005 | $10.09B | −$146.00M | -1.43% |
| Quarter ended Apr 2005 | $10.24B | −$199.00M | -1.91% |
| Quarter ended Dec 2004 | $10.44B | +$841.00M | +8.76% |
| Quarter ended Sep 2004 | $9.60B | +$38.00M | +0.40% |
| Quarter ended Jun 2004 | $9.56B | −$112.00M | -1.16% |
| Quarter ended Mar 2004 | $9.67B | −$177.00M | -1.80% |
| Quarter ended Dec 2003 | $9.85B | +$601.00M | +6.50% |
| Quarter ended Sep 2003 | $9.24B | +$181.00M | +2.00% |
| Quarter ended Jun 2003 | $9.06B | +$265.00M | +3.01% |
| Quarter ended Mar 2003 | $8.80B | +$89.00M | +1.02% |
| Quarter ended Dec 2002 | $8.71B | +$535.00M | +6.54% |
| Quarter ended Sep 2002 | $8.18B | N/A | N/A |